Markets

Will the NIH implement the proposed changes to its grant review process by February 2027?

Yes0%No0%
Loading...

About this market

This market resolves to Yes if the National Institutes of Health (NIH) officially implements the proposed changes to their grant review process, as described in recent news, by February 28, 2027. The changes involve moving away from transparent numerical scores to a few broad categories like 'Most competitive', 'Competitive', and 'Not discussed'.

Rules

  • Market closes February 28, 2027 (ET).
  • Logic weighted resolution applies.
Please log in to comment.
Logic: 88/100

The odds seem way too optimistic for the NIH to have this all sorted by February 2027. Historically, these kinds of procedural changes take years, not months. Plus, the last significant overhaul from them took about three years. I'd put the actual chance of implementation closer to 30 percent, not the current spread.

Logic Analysis
Fact Check(30%)
85/100
No Fallacies(25%)
90/100
Relevance(25%)
95/100
Logic/Emotion(20%)
80/100

Rationale:The comment provides a well-reasoned perspective based on historical context regarding the NIH's procedural changes, which supports a high score for Fact Check. It avoids logical fallacies and is directly relevant to the market question, though it does contain some emotional appeal regarding the perceived optimism of the odds. The weights reflect the importance of factual accuracy and logical reasoning in this analysis.

Logic: 85/100

The price seems a bit optimistic; implementing major changes within just a few months feels rushed given NIH’s usual pace, so I expect delays.

Logic Analysis
Fact Check(35%)
75/100
No Fallacies(30%)
90/100
Relevance(20%)
95/100
Logic/Emotion(15%)
85/100

Rationale:The comment reasonably assesses the timeline for NIH implementing changes, reflecting knowledge of NIH's typical pace, which is generally slower, though no specific data is cited. It is logically sound with no fallacies and directly relevant to the market question. The tone is mostly reasoned with some cautious skepticism, balancing logic and emotion well. Weighing fact check and no fallacies higher fits the nature of the comment.

Logic: 85/100

The current odds seem too high given the pushback in the scientific community about the changes, which suggests a lower likelihood of implementation.

Logic Analysis
Fact Check(30%)
80/100
No Fallacies(25%)
90/100
Relevance(25%)
90/100
Logic/Emotion(20%)
80/100

Rationale:The comment accurately reflects concerns from the scientific community regarding the proposed changes, which is a relevant factor in assessing the likelihood of implementation. It is logically sound and free from major fallacies, though it could benefit from more specific evidence to support the claim about the odds being too high. The weights prioritize relevance and logical soundness, given the comment's focus on the implications of community feedback.

devrajpNov 12
Logic: 84/100

Seems optimistic they’ll flip the whole review system by February. Bureaucracy and testing new criteria usually drag longer than expected. I'd short unless price drops way more.

Logic Analysis
Fact Check(30%)
75/100
No Fallacies(30%)
85/100
Relevance(25%)
95/100
Logic/Emotion(15%)
80/100

Rationale:The comment provides a reasonable, experience-based perspective on bureaucratic delays, which is generally accurate though not citing specific data, so Fact Check is moderate-high. The reasoning is logically sound with no fallacies detected. It directly addresses the market question by discussing the timeline and likelihood of implementation, hence high relevance. The tone is mostly logical with a slight emotional bias toward caution, so Logic/Emotion is moderately high. Weights emphasize Fact Check and No Fallacies due to the analytical nature of the comment.

Logic: 84/100

Current odds imply there's a solid chance of the NIH making those changes, but the historical average for such proposals getting implemented isn't very high. Feels overpriced to me based on past data.

Logic Analysis
Fact Check(30%)
80/100
No Fallacies(25%)
90/100
Relevance(25%)
85/100
Logic/Emotion(20%)
80/100

Rationale:The comment presents a reasonable analysis of the current odds and historical data regarding NIH proposals, which supports a mostly accurate fact check score. It avoids logical fallacies and is relevant to the market question, though it could benefit from more specific data to strengthen its claims. The weights reflect a balanced focus on factual accuracy and logical reasoning, given the reliance on historical data and odds.

Logic: 83/100

nah, that price feels a bit high. government stuff moves slow, especially big changes like this. i’d bet on delays or the changes getting watered down before february rolls around. not seeing enough urgency from the nih to hit that deadline solid.

Logic Analysis
Fact Check(30%)
75/100
No Fallacies(30%)
80/100
Relevance(25%)
95/100
Logic/Emotion(15%)
85/100

Rationale:The comment provides a reasonable prediction based on general knowledge about government processes, which is mostly accurate but lacks specific evidence, so Fact Check is moderate. The reasoning is logically sound with no major fallacies, and the comment is highly relevant to the market question. The tone is mostly logical with some mild emotional skepticism, so Logic/Emotion is rated accordingly. Weights emphasize Fact Check and No Fallacies due to the analytical nature of the comment.

Logic: 83/100

nah I don't see them rushing this through by Feb, these changes usually take way longer to iron out and get approved.

Logic Analysis
Fact Check(35%)
75/100
No Fallacies(30%)
85/100
Relevance(20%)
95/100
Logic/Emotion(15%)
80/100

Rationale:The comment provides a reasonable opinion that NIH changes typically take longer to implement, which aligns with general knowledge but lacks specific evidence, so Fact Check is moderate. The argument is logically sound with no fallacies detected. It is highly relevant to the market question, directly addressing the timeline. The tone is mostly logical with a slight informal style, so Logic/Emotion is rated fairly high. Weights emphasize Fact Check and No Fallacies due to the nature of the reasoning.

Logic: 83/100

The current odds seem low considering the NIH's recent efforts to streamline funding processes. They proposed these changes based on feedback, which suggests a strong intent to adapt. I’d be surprised if they don’t make progress by February 2027, so I might consider buying in at these prices.

Logic Analysis
Fact Check(30%)
80/100
No Fallacies(25%)
90/100
Relevance(25%)
85/100
Logic/Emotion(20%)
75/100

Rationale:The comment accurately reflects the NIH's intent to streamline funding processes based on feedback, which is a verifiable fact. It presents a logical argument without fallacies, though it does contain some emotional appeal regarding the speaker's surprise at potential outcomes. The weights emphasize fact-checking and relevance due to the reliance on current developments in NIH processes.

Logic: 83/100

I think the price is too high given the recent delays in NIH decision-making; they have a history of being slow to adapt, and I wouldn’t count on these changes happening by that deadline.

Logic Analysis
Fact Check(30%)
80/100
No Fallacies(25%)
90/100
Relevance(25%)
85/100
Logic/Emotion(20%)
75/100

Rationale:The comment accurately reflects concerns about the NIH's historical decision-making speed, which is a relevant factor in predicting the implementation of changes by February 2027. While the claim about delays is mostly accurate, it lacks specific evidence, leading to a slightly lower score for Fact Check. The comment is logically sound and directly addresses the market question, with a reasonable balance of logic and emotional appeal, justifying the chosen weights.

ivyplsAug 21
Logic: 83/100

tbh, I think the chances of NIH actually changing their grant review process by early 2027 are pretty low. They've been pretty set in their ways for a while now, and even if they do propose changes, getting everyone on board takes forever. The market seems overly optimistic here; I’m not convinced they’ll pull it off that quickly.

Logic Analysis
Fact Check(25%)
70/100
No Fallacies(30%)
90/100
Relevance(25%)
90/100
Logic/Emotion(20%)
80/100

Rationale:The comment presents a mostly accurate perspective on the NIH's historical resistance to change, which is a reasonable deduction but lacks specific evidence to fully support the claim. It is logically sound and directly addresses the market question, indicating skepticism about the proposed changes. The weights reflect a balanced emphasis on logical reasoning and relevance, with a slight focus on factual accuracy due to the lack of specific data backing the claims.